Vanguard Capital Management’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Vanguard Capital Management's ANRO Position: Q3 2026 in Review
Vanguard Capital Management increased its Alto Neuroscience (ANRO) stake by 22% in Q3 2026, buying an estimated $9.05M and bringing the position to 1,690,753 shares worth $43.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1967.
Vanguard Capital Management first reported a position in ANRO in Q1 2026 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Vanguard Capital Management held 1,690,753 shares of Alto Neuroscience worth $43.2M as of Q3 2026.
- Vanguard Capital Management bought 301,276 Alto Neuroscience shares in Q3 2026, an estimated $9.05M.
- Alto Neuroscience made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1967 holding.
- Vanguard Capital Management first reported a position in Alto Neuroscience in Q1 2026 and has held it in 3 quarters since.
- 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.